Effect of digital (mHealth) and paper-based self-management educational interventions on quality of life of patients with common chronic respiratory diseases (bronchial asthma and chronic obstructive pulmonary disease): A mixed-methods pragmatic, randomized controlled trial

Science and Engineering Research Board (SERB)0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•Inclusion criteria for patients with COPD:
•(1) Men and women aged <65 years with mild, moderate or severe COPD as per GOLD criteria;
•(2) Resident of Chandigarh Tricity or Ambala district;
•(3) Have basic digital literacy and have access to Android smart phones with internet connection;
•(4) Can read and write English, Hindi or Punjabi;
•(5) Consent to participate in the study.
•Inclusion criteria for patients with asthma:
•(1) Age 18-65 years and both sex with bronchial asthma;
•(2) Resident of Chandigarh Tricity or Ambala district;
•(3) Can read and write English, Hindi or Punjabi and have basic digital literacy;
•(4) Have access to Android smart phones with internet connection;
•(5) Ready to give written consent to participate in the study.

•Exclusion criteria for patients with COPD:
•(1) Patients with coexisting non-COPD pulmonary conditions (e.g., lung cancer, sarcoidosis, and others);
•(2) Prior lung-volume reduction surgery and/or lung transplant;
•(3) Long-term supplemental oxygen >=12h/day;
•(4) >6 weeks of oral corticosteroids;
•(5) Serious or uncontrolled comorbidities likely to interfere with the study.
•Exclusion criteria for patients with asthma:
•(1) Severe refractory asthma (defined as difficult to control asthma i.e., on high intensity treatment and uncontrolled asthma despite good adherence (>=80% of prescribed inhaled corticosteroids) to prescription and good inhalation technique);
•(2) Presence of any active lung disease other than asthma (e.g., COPD, lung cancer, sarcoidosis, active tuberculosis, chronic pulmonary aspergillosis, bronchiectasis, allergic broncho-pulmonary aspergillosis, interstitial lung disease) or underwent lung reduction or related surgical interventions;
•(3) Long-term supplemental oxygen or home NIV as these patients generally have end-stage lung disease and may not respond to our interventions;
•(4) Mental impairment or language difficulties that make informed consent impossible.

发起方

Science and Engineering Research Board (SERB)